# Potassium Hydroxide Impregnated Alumina (KOH-Alumina) as a Recyclable Catalyst for the Solvent-Free Multicomponent Synthesis of Highly Functionalized Substituted Pyridazines and/or Substituted Pyridazin-3(2H)-ones under Microwave Irradiation

Authors: Hormi Mecadon; Bekington Myrboh
Journal: ISRN Organic Chemistry
 (2011)

---

## Abstract

The work described herein employs potassium hydroxide impregnated alumina (KOH-alumina) as a mild, efficient, and recyclable catalyst for a one-pot solvent-free and environmentally safer synthesis of 3,4,6-triarylpyridazines and some substituted pyridazines from active methylene carbonyl species, 1,2-dicarbonyls, and hydrazine hydrate by microwave (MW) irradiation. The method offers highly convergent, inexpensive, and functionality-tolerable procedure for rapid access to important pyridazine compounds in good yields.


---

## Body

## 1. Introduction

Pyridazines have received considerable attention because of their important pharmacological and biological properties [1]. Several pyridazine compounds exhibit antimicrobial [2], potent analgesic [3], COX inhibitor [4], antidiabetic [5], antihypertensive [6], herbicidal [7], anticancer [8], and antifungal [9] activities. Further, various pyridazinones have been used as intermediates for drugs and agrochemicals [5] and blood platelet aggregation inhibitors [10].The synthesis of pyridazine frameworks has been achieved primarily by the addition of hydrazine or its derivative to an appropriate 1,4-diketones and 1,4-ketoacids [11–13]. Other various pyridazines particularly amino-pyridazines have been prepared from polyfunctionalized nitriles, especially via the Jaap-Klingemaan reaction [14–18]. The literature also showed the preparation of pyridazines and pyridazinones involving active methylene species, benzil, and hydrazine. However, the methods employed harsh bases [19–21] or acids [22] in presence of hazardous solvents, and also the reactions require long period of time to complete. Therefore, there is a need for developing a milder and safer solvent-free procedure for the synthesis of substituted pyridazines especially because of the rise in demand for environmentally benign organic synthesis.To address the challenge of green synthesis, multicomponent reactions (MCRs) provide a solution since they are more efficient, cost effective, and less wasteful than traditional methods. Such synthetic approach, however, when teamed with microwave (MW) irradiation, facilitates the reaction better as MW gives very efficient thermal management and atom efficiency thus resulting in faster reaction with an increased product yield. In another development, in recent years, the use of inorganic solid supports as catalysts for the synthesis of various biologically active molecules has increased tremendously. Among these inorganic solid supports, potassium hydroxide coated with alumina (KOH-alumina) has been a versatile reagent for various reactions and transformations such as in transesterification and biodiesel production [23–26], ester hydrolysis [27], selective alkylation [28–30], Michael addition [31], cyanoethylation [32], and gas phase dehydrogenations [33]. It has also been found that KOH-alumina exhibited the highest basicity and superior catalytic activity among the alumina-supported alkaline catalysts during transesterification processes [25]. Moreover, KOH-alumina can be prepared easily and is inexpensive. In view of these advantages in the applications of heterogeneous catalysts in the synthesis of heterocyclic compounds, we have chosen KOH-alumina (10% in alumina) for the synthesis of some substituted pyridazines.Therefore, based on our previous work on pyridazine synthesis [21] and in conjunction with our current research aimed at development of synthetic methodologies using solid support catalysts through MCR’s [34–36], we report herein the three-component neat synthesis of 3,4,5-triarylpyridazines and other substituted pyridazines using KOH-alumina (10 mol%) by the microwave irradiation technique (Scheme 1).Scheme 1
One-pot synthesis of substituted pyridazines.Initially, the three-component synthesis was optimized by irradiating a mixture of acetophenone (2a) (0.2 mL, 1.50 mmol), benzil (1) (0.32 g, 1.50 mmol) and hydrazine hydrate (3) (0.10 mL, 2.00 mmol) in presence of 5 mol% KOH-alumina in a microwave reactor at 100°C for three minutes which afforded the product 4a in 57% yield. The same reaction when irradiated for ten minutes gave 4a in 64% yield. By varying the amount of the catalyst and irradiation time, optimization was finally arrived at 10 mol% of KOH-alumina which significantly resulted in 89% of the product 4a (Table 1). In another attempt, the catalyst recovered from the reaction after filtration, and washing with ethyl acetate was used further for the condensation of acetophenone (2a) (0.20 mL, 1.50 mmol), benzil (1) (0.32 g, 1.50 mmol), and hydrazine hydrate (3) (0.10 mL, 2.00 mmol). Interestingly, the reaction was observed to complete within 15 min of irradiation giving 4a in 61% yield. The results of the reactions using recycled KOH-alumina are shown in Table 1.Table 1
Optimization of the reaction condition and the catalyst recyclability with compound4a.
EntryReaction conditionsTime (min)Yield (%)a1KOH-alumina (5 mol%)3572KOH-alumina (5 mol%)10643KOH-alumina (10 mol%)2604KOH-alumina (10 mol%)4725KOH-alumina (10 mol%)6896KOH-alumina (10 mol%)8887KOH-alumina (recycled once)15618KOH-alumina (recycled twice)18309KOH-alumina (recycled three times)2227aIsolated yields.Thus, the present method was employed for the synthesis of a series of 3,4,5-triarylpyridazines involving different aromatic ketones (4a–g, Table 2). Irrespective of the presence of different substituents in the ortho and para positions on the ring of various aromatic aldehydes, the reactions proceeded well to furnish the desired products in good yields (4a–g, Table 2). Unfortunately, the reaction performed with meta substituted aromatic ketones gave only unisolable intermediates and failed to furnish the desired products. On the other hand, polyaromatic acetophenones such as 2-acetylnaphthalene (2h) underwent reaction smoothly with benzil (1) and hydrazine hydrate (3) to afford the desired product 4hin 77% yield (entry 9, Table 2).Table 2
KOH-alumina (10 mol%) catalyzed solvent-free synthesis of substituted pyridazines under microwave (MW) irradiation.
EntrySubstrate2(R3)Substrate1 R1/R2Product4Time (min)Yield (%)aM.p. (°C)c1R3 = C6H5R1 = R2 = C6H54a689182–184[21]2R3 = 4-CH3C6H4R1 = R2 = C6H54b586160–162[21]3R3 = 2-CH3OC6H4R1 = R2 = C6H54c1076137–1394R3 = 4-CH3OC6H4R1 = R2 = C6H54d885b164–166[21]5R3 = 4-BrC6H4R1 = R2 = C6H54e881147–149[21]6R3 = 4-ClC6H4R1 = R2 = C6H54f676179–181[21]7R3 = 4-NO2C6H4R1 = R2 = C6H54g673b164–166[21]8R3 =R1 = R2 = C6H54h877b190–192[21]aSolated yield. bPurified by column chromatography. cLiterature references.Similarly, the scope of this methodology was extended to synthesize other substituted pyridazines involving different active methylene carbonyl compounds such as ethyl cyano acetate (5a), diethyl malonate (5b), ethyl acetoacetate (5c), and acetyl acetone (5d) (Scheme 2). In all the cases the reactions proceeded fairly well and afforded the desired products in good yields (6a–f), (Table 3).Table 3
KOH-alumina (10 mol%) catalyzed solvent-free synthesis of substituted pyridazines under microwave (MW) irradiation.
EntrySubstrate5(R4, R5)Substrate1 R1/R2Product6Time (min)Yield (%)aM.p. (°C)c1R4 = CN,R1 = R2 = C6H56a881270–272[19]R5 = COOC2H5 (5a)2(5a)R1 = R2 = H6b876b182–184[19]3(5a)R1 = R2 = CH36c887209–211[19]4R4 = R5 = COOC2H5 (5b)R1 = R2 = C6H56d882217–219[19]5R4 = COOC2H5,R1 = R2 = C6H56e88677–79[20]R5 = COCH3 (5c)6R4 = R5 = COCH3 (5d)R1 = R2 = C6H56f879132–134[20]aIsolated yield. bPurified by column chromatography. cLiterature references.Scheme 2
One-pot synthesis of substituted pyridazines.The reactions were clean and all the products were purified by simple work-up and crystallization except for products4d, 4g, 4h, and 6bwhich were purified by column chromatography using ethyl acetate and hexane. All the synthesized compounds were characterized by 1H NMR, 13C NMR, IR, Mass, and Elemental analyses which were found to be in good agreement with the expected data.From the mechanistic point of view, the formation of the triarlpyridazines4 probably takes place through the addition of hydrazine hydrate to the 1, 4-dicarbonyl species (8) formed in situ by reaction between the acetophenone (2) and 1,2-dicarbonyl compound (1) in a similar fashion as reported earlier [21]. The overall plausible mechanism for the formation of the triarylpyridazines is depicted in Scheme 3.Scheme 3
Plausible mechanism for the formation of substituted pyridazines.


## 2. Conclusion

In summary, we have established a mild and efficient method for the synthesis of highly functionalized substituted pyridazines and other substituted pyridazinones using KOH-alumina (10 mol%). More importantly, the methodology presented here offers milder, more efficient, and particularly an environmentally friendly approach towards the synthesis of pyridazines by the use of potassium hydroxide impregnated on alumina as a recyclable catalyst.


## 3. Experimental Section

All the chemicals obtained commercially were directly used without further purification. KOH-alumina was prepared according to the procedure reported by Sukata [28], however, as 10% of KOH adsorbed on neutral alumina. Melting points were recorded by open capillary tube method and were uncorrected. The thin layer chromatography was performed on ACME’s silica or Merck precoated silica gel and the components were visualized in iodine chamber or by potassium permanganate spray technique. Flash column chromatography was performed on Merck silica gel (60–120 mesh) using ethyl acetate-hexane (3 : 7) as the eluent. IR spectra were recorded with Perkin-Elmer FT-IR spectrometer. The 1H and 13C NMR were recorded with Bruker AVANCE II 400 FT-NMR machine with TMS as the internal standard. Mass spectra were recorded with Waters ZQ-4000 equipped with ESI and APCI mass detector, and CHN was analyzed on Perkin-Elmer PE 2400 Series II.


### 3.1. General Procedure

#### 3.1.1. Procedure for the Synthesis of4(a–h)

A thoroughly mixed aromatic ketone (2) (1.50 mmol), 1,2-dicarbonyl compound (1) (1.50 mmol), hydrazine hydrate (3) (0.1 mL, 2.00 mmol) in presence of 10 mol% KOH-alumina was irradiated in a Chem Discover microwave reactor at 100°C (power 200 W) at regular intervals of 60 sec for 5–10 min. On completion of the reaction (monitored by thin layer chromatography), the reaction mixture was diluted with ethyl acetate and filtered on a sintered funnel. It was further washed down with ethyl acetate (5 mL × 4). The filtrate was then worked up with cold water, and the organic layer was separated and dried with anhydrous Na2SO4. The organic filtrate was evaporated invacuo to afford the crude product which was crystallized from ethanol (4a, 4b, 4c, 4e, and 4f) or purified by flash column chromatography (4d, 4g, and 4h) over silica gel (60–120 mesh) using ethyl acetate-hexane (3 : 7) as the eluent to afford the 3,4,6-triarylpyridazines.


#### 3.1.2. Procedure for the Synthesis of6(a–f)

A thoroughly mixed 1,2-dicarbonyl compound (1) (1.50 mmol) and hydrazine hydrate (3) (2.00 mmol) was irradiated in a Chem Discover microwave reactor at 100°C (power 200 W) for 5 minutes. The mixture was cooled and then introduced therein the active methylene species (5) (1.50 mmol) and KOH-alumina (10 mol%). The components were mixed thoroughly and subjected to microwave irradiation at 100°C (power 200 W) for 3–6 minutes. On completion of the reaction (monitored by thin layer chromatography), the reaction mixture was diluted with ethyl acetate and filtered on a sintered funnel. It was further washed down with ethyl acetate (5 mL × 4). The filtrate was then worked up with cold water and the organic layer was separated and dried with anhydrous Na2SO4. The organic filtrate was evaporated invacuo to afford the crude product which was crystallized from ethanol (6a, 6c, 6d, 6e, and6f) or purified by flash column chromatography (6b) over silica gel (60–120 mesh) using ethyl acetate-hexane (3 : 7) as the eluent to afford the pure product.3,4,6-triphenylpyridazine (4a, Table 2)
White solid; mp 182–184°C;1H NMR (400 MHz, CDCl3): δH 7.27–7.89 (m, 13H, Ar-H), 8.20 (s, 1H, Ar-H), 8.20 (d, 2H, J=6.8 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 124.5, 126.6, 127.6, 128.3, 128.6, 129.5, 129.6, 135.4, 136.0, 136.6, 139.2, 157.2, 157.7 ppm; IR (KBr): νmax 1075, 1177, 1394, 1444, 1488, 1582, 2854, 2924, 3063 cm−1; MS (ES+) for C22H16N2 308.1 found 308.9 (M + H)+, 331.0 (M + Na)+; CHN calcd. for C22H16N2 C, 85.69; H, 5.23; N, 9.08 found C, 85.71; H, 5.38; N, 9.32.3,4-diphenyl-6-p-tolylpyridazine (4b, Table 2)
Light yellow solid; mp 160–162°C;1H NMR (400 MHz, CDCl3): δH 2.43 (s, 3H, CH3), 7.25–7.35 (m, 10H, Ar-H), 7.48 (d, 2H, J=6.8 Hz, Ar-H), 7.83 (s, 1H, Ar-H), 8.08 (d, 2H, J=8.0 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 21.4, 124.7, 126.9, 128.1, 128.7, 129.0, 129.8, 130.0, 133.0, 136.5, 137.1, 139.6, 140.4, 157.6, 157.9 ppm; IR (KBr): νmax 1079, 1222, 1367, 1419, 1592, 2867, 2923, 3019 cm−1; MS (ES+) for C23H18N2 322.1 found 323.0 (M + H)+, 345.0 (M + Na)+; CHN calcd. for C23H18N2 C, 85.68; H, 5.63; N, 8.69 found C,85.55; H, 5.65; N, 8.44.6-(2-methoxyphenyl)-3,4-diphenylpyridazine (4c, Table 2)
White solid; mp 137–139°C;1H NMR (400 MHz, CDCl3): δH 3.85 (s, 3H, OCH3), 7.00–7.30 (m, 12H, Ar-H), 7.43 (s, 1H, Ar-H), 8.03 (d, 2H, J=7.2 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 55.8, 111.4, 121.4, 124.7, 128.2, 128.7, 128.9, 129.2, 130.1, 131.5, 131.6, 136.3, 137.0, 139.1, 156.9, 157.3, 157.7 ppm; IR (KBr): νmax 1076, 1199, 1206, 1371, 1496, 1509, 2877, 2943, 3016 cm−1; MS (ES+) for C23H18N2O 338.1 found 339.0 (M + H)+, 361.0 (M + Na)+; CHN calcd. for C23H18N2O C, 81.63; H, 5.36; N, 8.28 found C, 81.59; H, 5.16; N, 8.35.6-(4-methoxyphenyl)-3,4-diphenylpyridazine (4d, Table 2)
Yellow solid; mp 164–166°C;1H NMR (400 MHz, CDCl3): δH 3.87 (s, 3H, OCH3), 7.04 (d, 2H, J=8.8 Hz, Ar-H), 7.21–7.35 (m, 8H, Ar-H), 7.47 (d, 2H, J=6.8 Hz, Ar-H), 7.79 (s, 1H, Ar-H), 8.15 (d, 2H, J=8.4 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 55.39, 114.4, 124.2, 128.2, 128.3, 128.4, 128.6, 128.7, 129.0, 130.0, 136.7, 137.2, 139.5, 157.2, 157.6, 161.3  ppm; IR (KBr): νmax 1067, 1208, 1310, 1487, 1562, 2877, 2931, 3012 cm−1; MS (ES+) for C23H18N2O 338.1 found 339.0 (M + H)+, 361.0 (M + Na)+; CHN calcd. for C23H18N2O C, 81.63; H, 5.36; N, 8.28 found C, 81.58; H, 5.29; N, 8.11.6-(4-bromophenyl)-3,4-diphenylpyridazine (4e, Table 2)
White solid; mp 147–149°C;1H NMR (400 MHz, CDCl3): δH 7.05–7.45 (m, 12H, Ar-H), 7.74 (s, 1H, Ar-H), 8.08 (d, 2H, J=6.8 Hz) ppm; 13C NMR (100 MHz, CDCl3): δC 122.6, 125.2, 126.9, 127.2, 128.2, 128.8, 128.9, 129.1, 130.1, 130.2, 131.6, 131.8, 135.8, 136.4, 137.0, 139.9, 157.7, 158.2 ppm; IR (KBr): νmax 1075, 1296, 1400, 1488, 1571, 2934, 3011 cm−1; MS (ES+) for C22H15BrN2 386.0 found 387.0 (M + H)+, 409.0 (M + Na)+; CHN calcd. for C22H15BrN2 C, 68.23; H, 3.90; N, 7.23 found C, 68.21; H, 3.73; N, 7.11.6-(4-chlorophenyl)-3,4-diphenylpyridazine (4f, Table 2)
Light yellow solid; mp 179–181°C;1H NMR (400 MHz, CDCl3): δH 7.06–7.44 (m, 12H, Ar-H), 7.73 (s, 1H, Ar-H), 8.08 (d, 2H, J=7.6 Hz) ppm; 13C NMR (100 MHz, CDCl3): δC 125.1, 126.4, 126.5, 127.1, 127.2, 128.2, 128.6, 128.9, 129.1, 129.5, 129.7, 130.1, 130.2, 135.9, 136.5, 139.8, 157.7, 158.2 ppm; IR (KBr): νmax 1076, 1200, 1301, 1481, 1546, 2879, 2932, 3088 cm−1; MS (ES+) for C22H15ClN2 342.1 found 343.0 (M + H)+, 365.0 (M + Na)+; CHN calcd. for C22H15ClN2 C, 77.08; H, 4.41; N, 8.17 found C, 77.26; H, 4.59; N, 8.06.6-(4-nitrophenyl)-3,4-diphenylpyridazine (4g, Table 2)
White solid; mp 164–166°C;1H NMR (400 MHz, CDCl3): δH 7.16–7.44 (m, 11H, Ar-H), 7.56 (t, 1H, J=7.2 Hz, Ar-H), 7.79 (s, 1H, Ar-H), 8.07 (d, 2H, J=8.0 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 123.0, 123.6, 126.1, 127.3, 128.2, 128.9, 129.0, 129.1, 129.3, 129.6, 134.4, 135.6, 140.9, 148.1, 157.6, 158.1 ppm; IR (KBr): νmax 1076, 1230, 1309, 1441, 1541, 2877, 2932, 3081 cm−1; MS (ES+) for C22H15N3O2 353.1 found 354.0 (M + H)+, 376.0 (M + Na)+; CHN calcd. for C22H15N3O2 C, 74.78; H, 4.28; N, 11.89 found C, 74.53; H, 4.40; N, 11.76.6-(naphthalen-2-yl)-3,4-diphenylpyridazine (4h, Table 2)
White solid; mp 190–192°C;1H NMR (400 MHz, CDCl3): δH 7.10–7.73 (m, 18H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δc 124.2, 125.4, 125.8, 126.1, 127.3, 127.9, 128.3, 128.8, 129.0, 129.1, 130.2, 130.3, 133.1, 135.6, 136.9, 157.7, 158.2 ppm; IR (KBr): νmax 1080, 1234, 1290, 1438, 1521, 2861, 2932, 2995, 3043 cm-1; MS (ES+) for C26H18N2 358.1 found 359.0 (M + H)+, 381.0 (M + Na)+; CHN calcd. for C26H18N2 C, 87.12; H, 5.06; N, 7.82 found C, 87.31; H, 5.21; N, 7.71.2,3-dihydro-3-oxo-5,6-diphenylpyridazine-4-carbonitrile (6a, Table 3)
White solid; mp 270–272°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 6.91–7.94 (m, 10H, Ar-H), 11.58 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 110.3, 116.5, 127.8, 128.9, 129.1, 129.6, 130.2, 131.4, 132.7, 133.6, 135.3, 146.9, 158.2 ppm; IR (KBr): νmax 1010, 1089, 1210, 1464, 1511, 1693, 2256, 2868, 2932, 3412 cm−1; MS (ES+) for C17H11N3O 273.1 found 274.0 (M + H)+, 296.0 (M + Na)+; CHN calcd. for C17H11N3O C, 74.71; H, 4.06; N, 15.38 found C, 74.86; H, 4.21; N, 15.12.2,3-dihydro-3-oxopyridazine-4-carbonitrile (6b, Table 3)
White solid; mp 182–184°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 7.24 (s, 1H, Ar-H), 7.63 (s, 1H, Ar-H), 11.57 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 110.4, 118.3, 138.7, 152.3, 168.8 ppm; IR (KBr): νmax 1089, 1212, 1400, 1526, 1676, 2247, 2881, 2932, 3310 cm−1; MS (ES+) for C5H3N3O 121.0 found 122.0 (M + H)+, 144.0 (M + Na)+; CHN calcd. for C5H3N3O C, 49.59; H, 2.50; N, 34.70 found C, 49.53; H, 2.41; N, 34.62.2,3-dihydro-5,6-dimethyl-3-oxopyridazine-4-carbonitrile (6c, Table 3)
White solid; mp 209–211°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 2.33 (s, 3H, CH3), 2.50 (s, 3H, CH3), 11.25 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 9.9, 27.6, 116.7, 126.2, 152.8, 157.4, 167.9 ppm; IR (KBr): νmax 1046, 1287, 1412, 1547, 1671, 2219, 2931, 3349 cm−1; MS (ES+) for C7H7N3O 149.1 found 150.0 (M + H)+, 172.0 (M + Na)+; CHN calcd. for C7H7N3O C, 56.37; H, 4.73; N, 28.17 found C, 56.21; H, 4.68; N, 28.32.Ethyl 2,3-dihydro-3-oxo-5,6-diphenylpyridazine-4-carboxylate (6d, Table 3)
White solid; mp 217–219°C;1H NMR (400 MHz, CDCl3): δH 0.90 (t, 3H, J=7.2 Hz, CH3), 4.05 (q, 2H, J=7.2 Hz, CH2), 7.03–7.27 (m, 10H, Ar-H), 12.56 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3): δC 13.7, 62.0, 128.0, 128.3, 128.7, 129.1, 129.2, 133.7, 133.8, 134.7, 143.3, 147.7, 158.7, 163.6 ppm; IR (KBr): νmax 1101, 1200, 1432, 1500, 1672, 1768, 2867, 2931, 3401 cm−1; MS (ES+) for C19H16N2O3 320.1 found 321.0 (M + H)+, 343.0 (M + Na)+; CHN calcd. for C19H16N2O3 C, 71.24; H, 5.03; N, 8.74 found C, 71.43; H, 5.17; N, 8.68.Ethyl 3-methyl-5,6-diphenylpyridazine-4-carboxylate (6e, Table 3)
White solid; mp 77–79°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 0.95 (t, 3H, J=7.4 Hz, CH3), 2.65 (s, 3H, CH3), 4.05 (q, 2H, J=7.6 Hz, CH2), 7.14–7.46 (m, 10H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 14.6, 23.7, 61.4, 126.7, 126.9, 127.5, 128.3, 128.8, 129.3, 130.1, 132.1, 132.7, 134.6, 137.8, 139.5, 141.0, 152.6, 196.3 ppm; IR (KBr): νmax 1087, 1100, 1280, 1434, 1510, 1769, 2862, 2932, 3084 cm−1; MS (ES+) for C20H18N2O2 318.1 found 319.0 (M + H)+, 341.0 (M + Na)+; CHN calcd. for C20H18N2O2 C, 75.45; H, 5.70; N, 8.80 found C, 75.57; H, 5.69; N, 8.82.1-(3-methyl-5,6-diphenylpyridazin-4-yl)ethanone (6f, Table 3)
White solid; mp 132–134°C;1H NMR (400 MHz, CDCl3): δH 1.82 (s, 3H, CH3), 2.59 (s, 3H, CH3), 7.18–7.47 (m, 10H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 21.9, 27.6, 126.7, 126.8, 128.5, 129.3, 129.7, 130.0, 134.6, 135.8, 136.6, 138.4, 138.8, 151.2, 152.3, 186.9 ppm; IR (KBr): νmax 1201, 1240, 1433, 1520, 1692, 2888, 2932, 3100 cm−1; MS (ES+) for C19H16N2O 288.1 found 289.0 (M + H)+, 311.0 (M + Na)+; CHN calcd. for C19H16N2O C, 79.14; H, 5.59; N, 9.72 found C, 79.33; H, 5.51; N, 9.77.


## 3.1. General Procedure

### 3.1.1. Procedure for the Synthesis of4(a–h)

A thoroughly mixed aromatic ketone (2) (1.50 mmol), 1,2-dicarbonyl compound (1) (1.50 mmol), hydrazine hydrate (3) (0.1 mL, 2.00 mmol) in presence of 10 mol% KOH-alumina was irradiated in a Chem Discover microwave reactor at 100°C (power 200 W) at regular intervals of 60 sec for 5–10 min. On completion of the reaction (monitored by thin layer chromatography), the reaction mixture was diluted with ethyl acetate and filtered on a sintered funnel. It was further washed down with ethyl acetate (5 mL × 4). The filtrate was then worked up with cold water, and the organic layer was separated and dried with anhydrous Na2SO4. The organic filtrate was evaporated invacuo to afford the crude product which was crystallized from ethanol (4a, 4b, 4c, 4e, and 4f) or purified by flash column chromatography (4d, 4g, and 4h) over silica gel (60–120 mesh) using ethyl acetate-hexane (3 : 7) as the eluent to afford the 3,4,6-triarylpyridazines.


### 3.1.2. Procedure for the Synthesis of6(a–f)

A thoroughly mixed 1,2-dicarbonyl compound (1) (1.50 mmol) and hydrazine hydrate (3) (2.00 mmol) was irradiated in a Chem Discover microwave reactor at 100°C (power 200 W) for 5 minutes. The mixture was cooled and then introduced therein the active methylene species (5) (1.50 mmol) and KOH-alumina (10 mol%). The components were mixed thoroughly and subjected to microwave irradiation at 100°C (power 200 W) for 3–6 minutes. On completion of the reaction (monitored by thin layer chromatography), the reaction mixture was diluted with ethyl acetate and filtered on a sintered funnel. It was further washed down with ethyl acetate (5 mL × 4). The filtrate was then worked up with cold water and the organic layer was separated and dried with anhydrous Na2SO4. The organic filtrate was evaporated invacuo to afford the crude product which was crystallized from ethanol (6a, 6c, 6d, 6e, and6f) or purified by flash column chromatography (6b) over silica gel (60–120 mesh) using ethyl acetate-hexane (3 : 7) as the eluent to afford the pure product.3,4,6-triphenylpyridazine (4a, Table 2)
White solid; mp 182–184°C;1H NMR (400 MHz, CDCl3): δH 7.27–7.89 (m, 13H, Ar-H), 8.20 (s, 1H, Ar-H), 8.20 (d, 2H, J=6.8 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 124.5, 126.6, 127.6, 128.3, 128.6, 129.5, 129.6, 135.4, 136.0, 136.6, 139.2, 157.2, 157.7 ppm; IR (KBr): νmax 1075, 1177, 1394, 1444, 1488, 1582, 2854, 2924, 3063 cm−1; MS (ES+) for C22H16N2 308.1 found 308.9 (M + H)+, 331.0 (M + Na)+; CHN calcd. for C22H16N2 C, 85.69; H, 5.23; N, 9.08 found C, 85.71; H, 5.38; N, 9.32.3,4-diphenyl-6-p-tolylpyridazine (4b, Table 2)
Light yellow solid; mp 160–162°C;1H NMR (400 MHz, CDCl3): δH 2.43 (s, 3H, CH3), 7.25–7.35 (m, 10H, Ar-H), 7.48 (d, 2H, J=6.8 Hz, Ar-H), 7.83 (s, 1H, Ar-H), 8.08 (d, 2H, J=8.0 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 21.4, 124.7, 126.9, 128.1, 128.7, 129.0, 129.8, 130.0, 133.0, 136.5, 137.1, 139.6, 140.4, 157.6, 157.9 ppm; IR (KBr): νmax 1079, 1222, 1367, 1419, 1592, 2867, 2923, 3019 cm−1; MS (ES+) for C23H18N2 322.1 found 323.0 (M + H)+, 345.0 (M + Na)+; CHN calcd. for C23H18N2 C, 85.68; H, 5.63; N, 8.69 found C,85.55; H, 5.65; N, 8.44.6-(2-methoxyphenyl)-3,4-diphenylpyridazine (4c, Table 2)
White solid; mp 137–139°C;1H NMR (400 MHz, CDCl3): δH 3.85 (s, 3H, OCH3), 7.00–7.30 (m, 12H, Ar-H), 7.43 (s, 1H, Ar-H), 8.03 (d, 2H, J=7.2 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 55.8, 111.4, 121.4, 124.7, 128.2, 128.7, 128.9, 129.2, 130.1, 131.5, 131.6, 136.3, 137.0, 139.1, 156.9, 157.3, 157.7 ppm; IR (KBr): νmax 1076, 1199, 1206, 1371, 1496, 1509, 2877, 2943, 3016 cm−1; MS (ES+) for C23H18N2O 338.1 found 339.0 (M + H)+, 361.0 (M + Na)+; CHN calcd. for C23H18N2O C, 81.63; H, 5.36; N, 8.28 found C, 81.59; H, 5.16; N, 8.35.6-(4-methoxyphenyl)-3,4-diphenylpyridazine (4d, Table 2)
Yellow solid; mp 164–166°C;1H NMR (400 MHz, CDCl3): δH 3.87 (s, 3H, OCH3), 7.04 (d, 2H, J=8.8 Hz, Ar-H), 7.21–7.35 (m, 8H, Ar-H), 7.47 (d, 2H, J=6.8 Hz, Ar-H), 7.79 (s, 1H, Ar-H), 8.15 (d, 2H, J=8.4 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 55.39, 114.4, 124.2, 128.2, 128.3, 128.4, 128.6, 128.7, 129.0, 130.0, 136.7, 137.2, 139.5, 157.2, 157.6, 161.3  ppm; IR (KBr): νmax 1067, 1208, 1310, 1487, 1562, 2877, 2931, 3012 cm−1; MS (ES+) for C23H18N2O 338.1 found 339.0 (M + H)+, 361.0 (M + Na)+; CHN calcd. for C23H18N2O C, 81.63; H, 5.36; N, 8.28 found C, 81.58; H, 5.29; N, 8.11.6-(4-bromophenyl)-3,4-diphenylpyridazine (4e, Table 2)
White solid; mp 147–149°C;1H NMR (400 MHz, CDCl3): δH 7.05–7.45 (m, 12H, Ar-H), 7.74 (s, 1H, Ar-H), 8.08 (d, 2H, J=6.8 Hz) ppm; 13C NMR (100 MHz, CDCl3): δC 122.6, 125.2, 126.9, 127.2, 128.2, 128.8, 128.9, 129.1, 130.1, 130.2, 131.6, 131.8, 135.8, 136.4, 137.0, 139.9, 157.7, 158.2 ppm; IR (KBr): νmax 1075, 1296, 1400, 1488, 1571, 2934, 3011 cm−1; MS (ES+) for C22H15BrN2 386.0 found 387.0 (M + H)+, 409.0 (M + Na)+; CHN calcd. for C22H15BrN2 C, 68.23; H, 3.90; N, 7.23 found C, 68.21; H, 3.73; N, 7.11.6-(4-chlorophenyl)-3,4-diphenylpyridazine (4f, Table 2)
Light yellow solid; mp 179–181°C;1H NMR (400 MHz, CDCl3): δH 7.06–7.44 (m, 12H, Ar-H), 7.73 (s, 1H, Ar-H), 8.08 (d, 2H, J=7.6 Hz) ppm; 13C NMR (100 MHz, CDCl3): δC 125.1, 126.4, 126.5, 127.1, 127.2, 128.2, 128.6, 128.9, 129.1, 129.5, 129.7, 130.1, 130.2, 135.9, 136.5, 139.8, 157.7, 158.2 ppm; IR (KBr): νmax 1076, 1200, 1301, 1481, 1546, 2879, 2932, 3088 cm−1; MS (ES+) for C22H15ClN2 342.1 found 343.0 (M + H)+, 365.0 (M + Na)+; CHN calcd. for C22H15ClN2 C, 77.08; H, 4.41; N, 8.17 found C, 77.26; H, 4.59; N, 8.06.6-(4-nitrophenyl)-3,4-diphenylpyridazine (4g, Table 2)
White solid; mp 164–166°C;1H NMR (400 MHz, CDCl3): δH 7.16–7.44 (m, 11H, Ar-H), 7.56 (t, 1H, J=7.2 Hz, Ar-H), 7.79 (s, 1H, Ar-H), 8.07 (d, 2H, J=8.0 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 123.0, 123.6, 126.1, 127.3, 128.2, 128.9, 129.0, 129.1, 129.3, 129.6, 134.4, 135.6, 140.9, 148.1, 157.6, 158.1 ppm; IR (KBr): νmax 1076, 1230, 1309, 1441, 1541, 2877, 2932, 3081 cm−1; MS (ES+) for C22H15N3O2 353.1 found 354.0 (M + H)+, 376.0 (M + Na)+; CHN calcd. for C22H15N3O2 C, 74.78; H, 4.28; N, 11.89 found C, 74.53; H, 4.40; N, 11.76.6-(naphthalen-2-yl)-3,4-diphenylpyridazine (4h, Table 2)
White solid; mp 190–192°C;1H NMR (400 MHz, CDCl3): δH 7.10–7.73 (m, 18H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δc 124.2, 125.4, 125.8, 126.1, 127.3, 127.9, 128.3, 128.8, 129.0, 129.1, 130.2, 130.3, 133.1, 135.6, 136.9, 157.7, 158.2 ppm; IR (KBr): νmax 1080, 1234, 1290, 1438, 1521, 2861, 2932, 2995, 3043 cm-1; MS (ES+) for C26H18N2 358.1 found 359.0 (M + H)+, 381.0 (M + Na)+; CHN calcd. for C26H18N2 C, 87.12; H, 5.06; N, 7.82 found C, 87.31; H, 5.21; N, 7.71.2,3-dihydro-3-oxo-5,6-diphenylpyridazine-4-carbonitrile (6a, Table 3)
White solid; mp 270–272°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 6.91–7.94 (m, 10H, Ar-H), 11.58 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 110.3, 116.5, 127.8, 128.9, 129.1, 129.6, 130.2, 131.4, 132.7, 133.6, 135.3, 146.9, 158.2 ppm; IR (KBr): νmax 1010, 1089, 1210, 1464, 1511, 1693, 2256, 2868, 2932, 3412 cm−1; MS (ES+) for C17H11N3O 273.1 found 274.0 (M + H)+, 296.0 (M + Na)+; CHN calcd. for C17H11N3O C, 74.71; H, 4.06; N, 15.38 found C, 74.86; H, 4.21; N, 15.12.2,3-dihydro-3-oxopyridazine-4-carbonitrile (6b, Table 3)
White solid; mp 182–184°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 7.24 (s, 1H, Ar-H), 7.63 (s, 1H, Ar-H), 11.57 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 110.4, 118.3, 138.7, 152.3, 168.8 ppm; IR (KBr): νmax 1089, 1212, 1400, 1526, 1676, 2247, 2881, 2932, 3310 cm−1; MS (ES+) for C5H3N3O 121.0 found 122.0 (M + H)+, 144.0 (M + Na)+; CHN calcd. for C5H3N3O C, 49.59; H, 2.50; N, 34.70 found C, 49.53; H, 2.41; N, 34.62.2,3-dihydro-5,6-dimethyl-3-oxopyridazine-4-carbonitrile (6c, Table 3)
White solid; mp 209–211°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 2.33 (s, 3H, CH3), 2.50 (s, 3H, CH3), 11.25 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 9.9, 27.6, 116.7, 126.2, 152.8, 157.4, 167.9 ppm; IR (KBr): νmax 1046, 1287, 1412, 1547, 1671, 2219, 2931, 3349 cm−1; MS (ES+) for C7H7N3O 149.1 found 150.0 (M + H)+, 172.0 (M + Na)+; CHN calcd. for C7H7N3O C, 56.37; H, 4.73; N, 28.17 found C, 56.21; H, 4.68; N, 28.32.Ethyl 2,3-dihydro-3-oxo-5,6-diphenylpyridazine-4-carboxylate (6d, Table 3)
White solid; mp 217–219°C;1H NMR (400 MHz, CDCl3): δH 0.90 (t, 3H, J=7.2 Hz, CH3), 4.05 (q, 2H, J=7.2 Hz, CH2), 7.03–7.27 (m, 10H, Ar-H), 12.56 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3): δC 13.7, 62.0, 128.0, 128.3, 128.7, 129.1, 129.2, 133.7, 133.8, 134.7, 143.3, 147.7, 158.7, 163.6 ppm; IR (KBr): νmax 1101, 1200, 1432, 1500, 1672, 1768, 2867, 2931, 3401 cm−1; MS (ES+) for C19H16N2O3 320.1 found 321.0 (M + H)+, 343.0 (M + Na)+; CHN calcd. for C19H16N2O3 C, 71.24; H, 5.03; N, 8.74 found C, 71.43; H, 5.17; N, 8.68.Ethyl 3-methyl-5,6-diphenylpyridazine-4-carboxylate (6e, Table 3)
White solid; mp 77–79°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 0.95 (t, 3H, J=7.4 Hz, CH3), 2.65 (s, 3H, CH3), 4.05 (q, 2H, J=7.6 Hz, CH2), 7.14–7.46 (m, 10H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 14.6, 23.7, 61.4, 126.7, 126.9, 127.5, 128.3, 128.8, 129.3, 130.1, 132.1, 132.7, 134.6, 137.8, 139.5, 141.0, 152.6, 196.3 ppm; IR (KBr): νmax 1087, 1100, 1280, 1434, 1510, 1769, 2862, 2932, 3084 cm−1; MS (ES+) for C20H18N2O2 318.1 found 319.0 (M + H)+, 341.0 (M + Na)+; CHN calcd. for C20H18N2O2 C, 75.45; H, 5.70; N, 8.80 found C, 75.57; H, 5.69; N, 8.82.1-(3-methyl-5,6-diphenylpyridazin-4-yl)ethanone (6f, Table 3)
White solid; mp 132–134°C;1H NMR (400 MHz, CDCl3): δH 1.82 (s, 3H, CH3), 2.59 (s, 3H, CH3), 7.18–7.47 (m, 10H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 21.9, 27.6, 126.7, 126.8, 128.5, 129.3, 129.7, 130.0, 134.6, 135.8, 136.6, 138.4, 138.8, 151.2, 152.3, 186.9 ppm; IR (KBr): νmax 1201, 1240, 1433, 1520, 1692, 2888, 2932, 3100 cm−1; MS (ES+) for C19H16N2O 288.1 found 289.0 (M + H)+, 311.0 (M + Na)+; CHN calcd. for C19H16N2O C, 79.14; H, 5.59; N, 9.72 found C, 79.33; H, 5.51; N, 9.77.


## 3.1.1. Procedure for the Synthesis of4(a–h)

A thoroughly mixed aromatic ketone (2) (1.50 mmol), 1,2-dicarbonyl compound (1) (1.50 mmol), hydrazine hydrate (3) (0.1 mL, 2.00 mmol) in presence of 10 mol% KOH-alumina was irradiated in a Chem Discover microwave reactor at 100°C (power 200 W) at regular intervals of 60 sec for 5–10 min. On completion of the reaction (monitored by thin layer chromatography), the reaction mixture was diluted with ethyl acetate and filtered on a sintered funnel. It was further washed down with ethyl acetate (5 mL × 4). The filtrate was then worked up with cold water, and the organic layer was separated and dried with anhydrous Na2SO4. The organic filtrate was evaporated invacuo to afford the crude product which was crystallized from ethanol (4a, 4b, 4c, 4e, and 4f) or purified by flash column chromatography (4d, 4g, and 4h) over silica gel (60–120 mesh) using ethyl acetate-hexane (3 : 7) as the eluent to afford the 3,4,6-triarylpyridazines.


## 3.1.2. Procedure for the Synthesis of6(a–f)

A thoroughly mixed 1,2-dicarbonyl compound (1) (1.50 mmol) and hydrazine hydrate (3) (2.00 mmol) was irradiated in a Chem Discover microwave reactor at 100°C (power 200 W) for 5 minutes. The mixture was cooled and then introduced therein the active methylene species (5) (1.50 mmol) and KOH-alumina (10 mol%). The components were mixed thoroughly and subjected to microwave irradiation at 100°C (power 200 W) for 3–6 minutes. On completion of the reaction (monitored by thin layer chromatography), the reaction mixture was diluted with ethyl acetate and filtered on a sintered funnel. It was further washed down with ethyl acetate (5 mL × 4). The filtrate was then worked up with cold water and the organic layer was separated and dried with anhydrous Na2SO4. The organic filtrate was evaporated invacuo to afford the crude product which was crystallized from ethanol (6a, 6c, 6d, 6e, and6f) or purified by flash column chromatography (6b) over silica gel (60–120 mesh) using ethyl acetate-hexane (3 : 7) as the eluent to afford the pure product.3,4,6-triphenylpyridazine (4a, Table 2)
White solid; mp 182–184°C;1H NMR (400 MHz, CDCl3): δH 7.27–7.89 (m, 13H, Ar-H), 8.20 (s, 1H, Ar-H), 8.20 (d, 2H, J=6.8 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 124.5, 126.6, 127.6, 128.3, 128.6, 129.5, 129.6, 135.4, 136.0, 136.6, 139.2, 157.2, 157.7 ppm; IR (KBr): νmax 1075, 1177, 1394, 1444, 1488, 1582, 2854, 2924, 3063 cm−1; MS (ES+) for C22H16N2 308.1 found 308.9 (M + H)+, 331.0 (M + Na)+; CHN calcd. for C22H16N2 C, 85.69; H, 5.23; N, 9.08 found C, 85.71; H, 5.38; N, 9.32.3,4-diphenyl-6-p-tolylpyridazine (4b, Table 2)
Light yellow solid; mp 160–162°C;1H NMR (400 MHz, CDCl3): δH 2.43 (s, 3H, CH3), 7.25–7.35 (m, 10H, Ar-H), 7.48 (d, 2H, J=6.8 Hz, Ar-H), 7.83 (s, 1H, Ar-H), 8.08 (d, 2H, J=8.0 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 21.4, 124.7, 126.9, 128.1, 128.7, 129.0, 129.8, 130.0, 133.0, 136.5, 137.1, 139.6, 140.4, 157.6, 157.9 ppm; IR (KBr): νmax 1079, 1222, 1367, 1419, 1592, 2867, 2923, 3019 cm−1; MS (ES+) for C23H18N2 322.1 found 323.0 (M + H)+, 345.0 (M + Na)+; CHN calcd. for C23H18N2 C, 85.68; H, 5.63; N, 8.69 found C,85.55; H, 5.65; N, 8.44.6-(2-methoxyphenyl)-3,4-diphenylpyridazine (4c, Table 2)
White solid; mp 137–139°C;1H NMR (400 MHz, CDCl3): δH 3.85 (s, 3H, OCH3), 7.00–7.30 (m, 12H, Ar-H), 7.43 (s, 1H, Ar-H), 8.03 (d, 2H, J=7.2 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 55.8, 111.4, 121.4, 124.7, 128.2, 128.7, 128.9, 129.2, 130.1, 131.5, 131.6, 136.3, 137.0, 139.1, 156.9, 157.3, 157.7 ppm; IR (KBr): νmax 1076, 1199, 1206, 1371, 1496, 1509, 2877, 2943, 3016 cm−1; MS (ES+) for C23H18N2O 338.1 found 339.0 (M + H)+, 361.0 (M + Na)+; CHN calcd. for C23H18N2O C, 81.63; H, 5.36; N, 8.28 found C, 81.59; H, 5.16; N, 8.35.6-(4-methoxyphenyl)-3,4-diphenylpyridazine (4d, Table 2)
Yellow solid; mp 164–166°C;1H NMR (400 MHz, CDCl3): δH 3.87 (s, 3H, OCH3), 7.04 (d, 2H, J=8.8 Hz, Ar-H), 7.21–7.35 (m, 8H, Ar-H), 7.47 (d, 2H, J=6.8 Hz, Ar-H), 7.79 (s, 1H, Ar-H), 8.15 (d, 2H, J=8.4 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 55.39, 114.4, 124.2, 128.2, 128.3, 128.4, 128.6, 128.7, 129.0, 130.0, 136.7, 137.2, 139.5, 157.2, 157.6, 161.3  ppm; IR (KBr): νmax 1067, 1208, 1310, 1487, 1562, 2877, 2931, 3012 cm−1; MS (ES+) for C23H18N2O 338.1 found 339.0 (M + H)+, 361.0 (M + Na)+; CHN calcd. for C23H18N2O C, 81.63; H, 5.36; N, 8.28 found C, 81.58; H, 5.29; N, 8.11.6-(4-bromophenyl)-3,4-diphenylpyridazine (4e, Table 2)
White solid; mp 147–149°C;1H NMR (400 MHz, CDCl3): δH 7.05–7.45 (m, 12H, Ar-H), 7.74 (s, 1H, Ar-H), 8.08 (d, 2H, J=6.8 Hz) ppm; 13C NMR (100 MHz, CDCl3): δC 122.6, 125.2, 126.9, 127.2, 128.2, 128.8, 128.9, 129.1, 130.1, 130.2, 131.6, 131.8, 135.8, 136.4, 137.0, 139.9, 157.7, 158.2 ppm; IR (KBr): νmax 1075, 1296, 1400, 1488, 1571, 2934, 3011 cm−1; MS (ES+) for C22H15BrN2 386.0 found 387.0 (M + H)+, 409.0 (M + Na)+; CHN calcd. for C22H15BrN2 C, 68.23; H, 3.90; N, 7.23 found C, 68.21; H, 3.73; N, 7.11.6-(4-chlorophenyl)-3,4-diphenylpyridazine (4f, Table 2)
Light yellow solid; mp 179–181°C;1H NMR (400 MHz, CDCl3): δH 7.06–7.44 (m, 12H, Ar-H), 7.73 (s, 1H, Ar-H), 8.08 (d, 2H, J=7.6 Hz) ppm; 13C NMR (100 MHz, CDCl3): δC 125.1, 126.4, 126.5, 127.1, 127.2, 128.2, 128.6, 128.9, 129.1, 129.5, 129.7, 130.1, 130.2, 135.9, 136.5, 139.8, 157.7, 158.2 ppm; IR (KBr): νmax 1076, 1200, 1301, 1481, 1546, 2879, 2932, 3088 cm−1; MS (ES+) for C22H15ClN2 342.1 found 343.0 (M + H)+, 365.0 (M + Na)+; CHN calcd. for C22H15ClN2 C, 77.08; H, 4.41; N, 8.17 found C, 77.26; H, 4.59; N, 8.06.6-(4-nitrophenyl)-3,4-diphenylpyridazine (4g, Table 2)
White solid; mp 164–166°C;1H NMR (400 MHz, CDCl3): δH 7.16–7.44 (m, 11H, Ar-H), 7.56 (t, 1H, J=7.2 Hz, Ar-H), 7.79 (s, 1H, Ar-H), 8.07 (d, 2H, J=8.0 Hz, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 123.0, 123.6, 126.1, 127.3, 128.2, 128.9, 129.0, 129.1, 129.3, 129.6, 134.4, 135.6, 140.9, 148.1, 157.6, 158.1 ppm; IR (KBr): νmax 1076, 1230, 1309, 1441, 1541, 2877, 2932, 3081 cm−1; MS (ES+) for C22H15N3O2 353.1 found 354.0 (M + H)+, 376.0 (M + Na)+; CHN calcd. for C22H15N3O2 C, 74.78; H, 4.28; N, 11.89 found C, 74.53; H, 4.40; N, 11.76.6-(naphthalen-2-yl)-3,4-diphenylpyridazine (4h, Table 2)
White solid; mp 190–192°C;1H NMR (400 MHz, CDCl3): δH 7.10–7.73 (m, 18H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δc 124.2, 125.4, 125.8, 126.1, 127.3, 127.9, 128.3, 128.8, 129.0, 129.1, 130.2, 130.3, 133.1, 135.6, 136.9, 157.7, 158.2 ppm; IR (KBr): νmax 1080, 1234, 1290, 1438, 1521, 2861, 2932, 2995, 3043 cm-1; MS (ES+) for C26H18N2 358.1 found 359.0 (M + H)+, 381.0 (M + Na)+; CHN calcd. for C26H18N2 C, 87.12; H, 5.06; N, 7.82 found C, 87.31; H, 5.21; N, 7.71.2,3-dihydro-3-oxo-5,6-diphenylpyridazine-4-carbonitrile (6a, Table 3)
White solid; mp 270–272°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 6.91–7.94 (m, 10H, Ar-H), 11.58 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 110.3, 116.5, 127.8, 128.9, 129.1, 129.6, 130.2, 131.4, 132.7, 133.6, 135.3, 146.9, 158.2 ppm; IR (KBr): νmax 1010, 1089, 1210, 1464, 1511, 1693, 2256, 2868, 2932, 3412 cm−1; MS (ES+) for C17H11N3O 273.1 found 274.0 (M + H)+, 296.0 (M + Na)+; CHN calcd. for C17H11N3O C, 74.71; H, 4.06; N, 15.38 found C, 74.86; H, 4.21; N, 15.12.2,3-dihydro-3-oxopyridazine-4-carbonitrile (6b, Table 3)
White solid; mp 182–184°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 7.24 (s, 1H, Ar-H), 7.63 (s, 1H, Ar-H), 11.57 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 110.4, 118.3, 138.7, 152.3, 168.8 ppm; IR (KBr): νmax 1089, 1212, 1400, 1526, 1676, 2247, 2881, 2932, 3310 cm−1; MS (ES+) for C5H3N3O 121.0 found 122.0 (M + H)+, 144.0 (M + Na)+; CHN calcd. for C5H3N3O C, 49.59; H, 2.50; N, 34.70 found C, 49.53; H, 2.41; N, 34.62.2,3-dihydro-5,6-dimethyl-3-oxopyridazine-4-carbonitrile (6c, Table 3)
White solid; mp 209–211°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 2.33 (s, 3H, CH3), 2.50 (s, 3H, CH3), 11.25 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 9.9, 27.6, 116.7, 126.2, 152.8, 157.4, 167.9 ppm; IR (KBr): νmax 1046, 1287, 1412, 1547, 1671, 2219, 2931, 3349 cm−1; MS (ES+) for C7H7N3O 149.1 found 150.0 (M + H)+, 172.0 (M + Na)+; CHN calcd. for C7H7N3O C, 56.37; H, 4.73; N, 28.17 found C, 56.21; H, 4.68; N, 28.32.Ethyl 2,3-dihydro-3-oxo-5,6-diphenylpyridazine-4-carboxylate (6d, Table 3)
White solid; mp 217–219°C;1H NMR (400 MHz, CDCl3): δH 0.90 (t, 3H, J=7.2 Hz, CH3), 4.05 (q, 2H, J=7.2 Hz, CH2), 7.03–7.27 (m, 10H, Ar-H), 12.56 (s, 1H, NH) ppm; 13C NMR (100 MHz, CDCl3): δC 13.7, 62.0, 128.0, 128.3, 128.7, 129.1, 129.2, 133.7, 133.8, 134.7, 143.3, 147.7, 158.7, 163.6 ppm; IR (KBr): νmax 1101, 1200, 1432, 1500, 1672, 1768, 2867, 2931, 3401 cm−1; MS (ES+) for C19H16N2O3 320.1 found 321.0 (M + H)+, 343.0 (M + Na)+; CHN calcd. for C19H16N2O3 C, 71.24; H, 5.03; N, 8.74 found C, 71.43; H, 5.17; N, 8.68.Ethyl 3-methyl-5,6-diphenylpyridazine-4-carboxylate (6e, Table 3)
White solid; mp 77–79°C;1H NMR (400 MHz, CDCl3 + DMSO-d6): δH 0.95 (t, 3H, J=7.4 Hz, CH3), 2.65 (s, 3H, CH3), 4.05 (q, 2H, J=7.6 Hz, CH2), 7.14–7.46 (m, 10H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3 + DMSO-d6): δC 14.6, 23.7, 61.4, 126.7, 126.9, 127.5, 128.3, 128.8, 129.3, 130.1, 132.1, 132.7, 134.6, 137.8, 139.5, 141.0, 152.6, 196.3 ppm; IR (KBr): νmax 1087, 1100, 1280, 1434, 1510, 1769, 2862, 2932, 3084 cm−1; MS (ES+) for C20H18N2O2 318.1 found 319.0 (M + H)+, 341.0 (M + Na)+; CHN calcd. for C20H18N2O2 C, 75.45; H, 5.70; N, 8.80 found C, 75.57; H, 5.69; N, 8.82.1-(3-methyl-5,6-diphenylpyridazin-4-yl)ethanone (6f, Table 3)
White solid; mp 132–134°C;1H NMR (400 MHz, CDCl3): δH 1.82 (s, 3H, CH3), 2.59 (s, 3H, CH3), 7.18–7.47 (m, 10H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δC 21.9, 27.6, 126.7, 126.8, 128.5, 129.3, 129.7, 130.0, 134.6, 135.8, 136.6, 138.4, 138.8, 151.2, 152.3, 186.9 ppm; IR (KBr): νmax 1201, 1240, 1433, 1520, 1692, 2888, 2932, 3100 cm−1; MS (ES+) for C19H16N2O 288.1 found 289.0 (M + H)+, 311.0 (M + Na)+; CHN calcd. for C19H16N2O C, 79.14; H, 5.59; N, 9.72 found C, 79.33; H, 5.51; N, 9.77.



---

*Source: 406427-2011-04-12.xml*